EDTUTC-4 New YorkLog in Sign up

NKTR
Nektar Therapeutics
stockNASDAQ

At CloseOct 2, 2026 3:59:51 PM EDT

43.66USD-7.087%(-3.33)2,923,413

Pre-marketOct 2, 2026 9:27:30 AM EDT

47.10USD+0.234%(+0.11)

After-hoursOct 2, 2026 4:39:30 PM EDT

43.58USD-0.183%(-0.08)

NKTR News

Day breaks

07:42 AM EDTH.C. Wainwright reiterates Nektar Therapeutics stock rating on alopecia data ·

Investing.com

03:26 PM EDTNoteworthy Thursday Option Activity: NKTR, MSGS, TRNS ·

BNK Invest

01:40 PM EDTNektar drops after new mid-stage trial data for hair loss drug ·

Seeking Alpha

12:50 PM EDTNektar Therapeutics (NKTR) Shareholder/Analyst Call Transcript ·

Seeking Alpha

12:23 PM EDTThis Biotech Had Good News for Hair Loss Sufferers. So Why Is the Stock Sinking? ·

Barron's

10:07 AM EDTNektar Posted Promising Alopecia Results. Here's Why It Took A 22% Beating. ·

Investor's Business Daily

08:40 AM EDT/UPDATE -- Nektar Therapeutics/ ·

PR Newswire

10:30 AM EDTNew Biomarker Data Presented in a Late Breaking Oral Presentation at EADV Congress 2026 Showing Early Molecular Responses to Rezpegaldesleukin Across Multiple Immune Pathways Dysregulated in Patients with Atopic Dermatitis ·

PR Newswire

04:15 PM EDTNektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ·

PR Newswire

09:17 AM EDTNektar Therapeutics stock rises on $90M jury verdict vs Lilly ·

Investing.com

08:49 AM EDTWhy is Nektar Therapeutics stock climbing today? ·

Investing.com

07:32 AM EDTNektar Therapeutics awarded $90 million in jury verdict against Eli Lilly ·

Investing.com

07:26 AM EDTNektar gains 5% as jury awards $90M plus interest in Lilly trial ·

Seeking Alpha

03:17 PM EDTNektar Therapeutics drops as jury deliberates in Eli Lilly patent dispute over Rezpeg ·

Seeking Alpha

02:19 PM EDTNektar Therapeutics options flow shows bullish bets against a bearish tape ·

Investing.com